Aparna Vasanthakumar
AbbVie (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Neuroblastoma Research and Treatments, Acute Myeloid Leukemia Research, Cancer-related gene regulation, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation(2010)2,713 cited
- → Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation(2011)1,292 cited
- → Dnmt3a is essential for hematopoietic stem cell differentiation(2011)1,093 cited
- → 5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging(2011)832 cited
- → Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis(2012)802 cited
- → DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia(2014)260 cited
- → Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma(2013)212 cited
- → Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors(2011)173 cited
- → TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma(2014)170 cited
- → DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation(2011)145 cited